Artigo quarta-feira 7th outubro 2026

Beyond the buzzword: The Longevity Economy

Longevity is moving beyond the world of biohackers and early adopters. As consumers increasingly focus on not simply living longer, but living better for longer, a much broader consumer health opportunity is beginning to emerge.

 

The idea of longevity has gained significant traction in recent years. Rising awareness of the difference between lifespan and healthspan, a growing focus on preventative health and greater access to health information, testing and treatment are changing how consumers think about ageing and their long-term health.

Longevity is not a single category. It is an increasingly interconnected ecosystem spanning diagnostics and monitoring, supplements and ingestibles, services and clinics, and beauty and aesthetics. Together, these markets are bringing established consumer health needs together with new technologies, emerging science and changing attitudes towards ageing.

Our latest report, developed with Perella Weinberg, explores how this Longevity Economy is developing, where opportunities for growth are emerging and what it will take to build propositions capable of creating sustainable long-term value.

From living longer to living better

At the heart of the longevity opportunity is a shift from reacting to ageing towards proactively maintaining health and performance.

For most consumers, that does not necessarily mean pursuing the more extreme promise of extending lifespan. Instead, longevity is increasingly about healthspan: remaining physically and mentally capable, energetic and resilient for longer. This is helping longevity reach far beyond its original audience of affluent, highly experimental biohackers. Research-led health ‘optimisers’ and performance-focused consumers are being joined by people motivated by maintaining physical capability, preventing age-related decline or preserving their appearance. Different groups bring very different needs, expectations and willingness to spend.

As longevity becomes more mainstream, businesses have an opportunity to address a considerably broader pool of demand – but brands must recognise that a single proposition is unlikely to resonate equally with every longevity consumer.

An ecosystem beginning to converge

The longevity market is developing from multiple directions; diagnostics and wearables are giving consumers more continuous and personalised insight into their health, supplements provide an accessible way to act on longevity-related needs, from metabolic and musculoskeletal health to cognition and the microbiome, and clinics are bringing together diagnostics and specialist interventions, while beauty and aesthetics are increasingly shifting towards preventative, restorative and regenerative outcomes.

The boundaries between these segments are also starting to blur. Emerging platforms and integrated clinics are combining diagnostics, products, services and personalised recommendations into broader propositions, helping consumers navigate what remains a fragmented and technically complex market.

As the ecosystem develops, some parts of longevity are likely to become increasingly accessible and mainstream, while more expensive or experimental interventions may remain the preserve of highly engaged consumers.

Turning longevity into lasting value

For businesses and investors, growing consumer interest alone will not guarantee attractive returns.

One of the biggest challenges is efficacy. The promise to “live longer” is inherently difficult for consumers to assess, meaning successful propositions need to translate a long-term, preventative benefit into something credible and tangible today. That could come through shorter-term benefits consumers can feel, robust proposition-specific scientific evidence, measurable data or targeted social proof.

Differentiation will become equally important as competition increases. Across the ecosystem, our analysis identifies four emerging requirements for success: access to a sufficiently large consumer opportunity; strong consumer-perceived efficacy; a defensible brand or product proposition; and an efficient, repeatable revenue model capable of supporting attractive economics.

The Longevity Economy remains at an early stage, particularly in Europe. That creates significant opportunity, but also leaves important questions unresolved: who will consumers trust, where will new propositions emerge, which business models will successfully scale, and where will the most defensible pools of value ultimately sit?

Read the full report to explore the emerging longevity ecosystem, the consumers shaping its development and the opportunities for businesses and investors as the market evolves.

Contatos principais

Anthony Gent

Anthony Gent

Partner

Coye Nokes

Coye Nokes

Partner

Artigos sugeridos

Ver todos os artigos

terça-feira 25th agosto 2026

The Winning Formula: The New Rules of Value Creation in Ingredients

After several years of volatility, the ingredients sector is entering a more demanding phase. Find out what that means for brands and investors.
Ler o artigo

quarta-feira 19th agosto 2026

Spirits M&A: a reset, not a retreat

After a decade of premiumisation-led growth, the Spirits sector is entering a more selective phase.
Ler o artigo

quinta-feira 19th junho 2025

Understanding the GLP-1 Effect on Consumption Behavior

GLP-1 medications such as Ozempic and Wegovy, reduce caloric intake by mimicking satiety hormones, slowing gastric emptying, and modulating brain reward signals related to...
Ler o artigo

quinta-feira 12th junho 2025

The Changing Face of Beauty M&A – How disruption has created a window for new investors

The Beauty & Personal Care (BPC) sector has long delivered strong growth, ahead of the wider CPG landscape. Its combination of emotional engagement, innovation,...
Ler o artigo